We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Compared to Estimates, Intuitive Surgical (ISRG) Q2 Earnings: A Look at Key Metrics
Read MoreHide Full Article
Intuitive Surgical, Inc. (ISRG - Free Report) reported $2.01 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 14.5%. EPS of $1.78 for the same period compares to $1.42 a year ago.
The reported revenue represents a surprise of +2.02% over the Zacks Consensus Estimate of $1.97 billion. With the consensus EPS estimate being $1.53, the EPS surprise was +16.34%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Intuitive Surgical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Total System Units Placed - Total Company: 341 versus the five-analyst average estimate of 309.
Da Vinci Surgical System Installed Base: 9,203 versus the four-analyst average estimate of 9,174.
Total System Units Placed - United States: 149 versus the two-analyst average estimate of 133.
Revenue- Product (Instruments and accessories and Systems): $1.69 billion compared to the $1.63 billion average estimate based on eight analysts. The reported number represents a change of +15.3% year over year.
Revenue- Services: $317.30 million compared to the $326.66 million average estimate based on eight analysts. The reported number represents a change of +10.4% year over year.
Revenue- Systems: $448.20 million versus $404.60 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +14.1% change.
Revenue- Instruments and accessories: $1.24 billion compared to the $1.23 billion average estimate based on eight analysts. The reported number represents a change of +15.7% year over year.
Gross profit- Service: $219.50 million versus $221.51 million estimated by two analysts on average.
Gross profit- Product: $1.15 billion versus the two-analyst average estimate of $1.06 billion.
Shares of Intuitive Surgical have returned -2% over the past month versus the Zacks S&P 500 composite's +2.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Compared to Estimates, Intuitive Surgical (ISRG) Q2 Earnings: A Look at Key Metrics
Intuitive Surgical, Inc. (ISRG - Free Report) reported $2.01 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 14.5%. EPS of $1.78 for the same period compares to $1.42 a year ago.
The reported revenue represents a surprise of +2.02% over the Zacks Consensus Estimate of $1.97 billion. With the consensus EPS estimate being $1.53, the EPS surprise was +16.34%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Intuitive Surgical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Total System Units Placed - Total Company: 341 versus the five-analyst average estimate of 309.
- Da Vinci Surgical System Installed Base: 9,203 versus the four-analyst average estimate of 9,174.
- Total System Units Placed - United States: 149 versus the two-analyst average estimate of 133.
- Revenue- Product (Instruments and accessories and Systems): $1.69 billion compared to the $1.63 billion average estimate based on eight analysts. The reported number represents a change of +15.3% year over year.
- Revenue- Services: $317.30 million compared to the $326.66 million average estimate based on eight analysts. The reported number represents a change of +10.4% year over year.
- Revenue- Systems: $448.20 million versus $404.60 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +14.1% change.
- Revenue- Instruments and accessories: $1.24 billion compared to the $1.23 billion average estimate based on eight analysts. The reported number represents a change of +15.7% year over year.
- Gross profit- Service: $219.50 million versus $221.51 million estimated by two analysts on average.
- Gross profit- Product: $1.15 billion versus the two-analyst average estimate of $1.06 billion.
View all Key Company Metrics for Intuitive Surgical here>>>Shares of Intuitive Surgical have returned -2% over the past month versus the Zacks S&P 500 composite's +2.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.